Skip to main content
. 2023 Jun 10:1–17. Online ahead of print. doi: 10.1007/s11940-023-00756-5

Table 2.

Summary of infectious agent, affected ganglioside(s), and clinical features in GBS

Infectious agent Ganglioside Clinical features
C. jejuni GM1, GM1b, GD1a, GalNac-GD1a AMAN most commonly; worse prognosis
CMV GM2 AIDP; good prognosis
HEV GM1/GM2? AIDP most common
M. Pneumoniae Gal-C AIDP; facial paresis
EBV Unknown AIDP; good prognosis
Arboviruses Unknown Facial paresis for Zika